We are live on ! Find out more
BLTE

Belite Bio
BLTE

17 hedge funds and large institutions have $8.12M invested in Belite Bio in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

157% more capital invested

Capital invested by funds: $3.17M → $8.12M (+$4.96M)

143% more funds holding

Funds holding: 7 → 17 (+10)

0.31% more ownership

Funds ownership: 0.39% → 0.7% (+0.31%)

Holders
17
Holders Change
+10
Holders Change %
+142.86%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.71M
2
AC
Armistice Capital
New York
+$1.38M
3
CSS
Cubist Systematic Strategies
Connecticut
+$649K
4
Marshall Wace
Marshall Wace
United Kingdom
+$615K
5
JP Morgan Chase
JP Morgan Chase
New York
+$548K

Top Sellers

Rank Fund Capital Flow
1
AWS
Atria Wealth Solutions
New York
-$2.36M
2
UBS Group
UBS Group
Switzerland
-$20.6K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$16.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$2.05M +$1.71M +44,404 +10,138%
AC
2
Armistice Capital
New York
$1.65M +$1.38M +36,000 New
State Street
3
State Street
Massachusetts
$803K +$22.8K +592 +3%
CSS
4
Cubist Systematic Strategies
Connecticut
$772K +$649K +16,882 New
Marshall Wace
5
Marshall Wace
United Kingdom
$733K +$615K +16,011 New
JP Morgan Chase
6
JP Morgan Chase
New York
$653K +$548K +14,267 New
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$352K +$296K +7,700 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$307K – – –
JF
9
Jump Financial
Illinois
$238K +$200K +5,200 New
Renaissance Technologies
10
Renaissance Technologies
New York
$224K +$188K +4,900 New
Bank of America
11
Bank of America
North Carolina
$101K +$82.4K +2,143 +3,402%
VEA
12
Virtus ETF Advisers
New York
$95.9K +$80.6K +2,096 New
BlackRock
13
BlackRock
New York
$82.6K +$69.4K +1,805 New
EC
14
EntryPoint Capital
New York
$35.7K +$30K +781 New
UBS Group
15
UBS Group
Switzerland
$15.9K -$20.6K -535 -61%
GI
16
GAMMA Investing
California
$8.64K +$7.65K +199 New
Osaic Holdings
17
Osaic Holdings
Arizona
$1.65K +$1.38K +36 New
AWS
18
Atria Wealth Solutions
New York
– -$2.36M -74,019 Closed
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
– -$16.6K -525 Closed

BLTE Hedge Fund Activity: Q4 2023 in Review

17 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q4 2023, worth a combined $8.12M — up 157% from $3.17M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BLTE positions and 2 closed out — a net gain of 10 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.71M. The largest seller was Atria Wealth Solutions, exiting entirely with an estimated $2.36M sold.

  • 17 institutional investors held Belite Bio (BLTE) as of Q4 2023, up from 7 in Q3 2023.
  • Funds reported $8.12M of Belite Bio stock for Q4 2023, up 157% quarter-over-quarter.
  • 12 funds opened new Belite Bio positions in Q4 2023 and 2 closed out, a net change of +10 holders.
  • The largest Belite Bio buyer in Q4 2023 was Morgan Stanley, an estimated $1.71M added.
  • The largest Belite Bio seller in Q4 2023 was Atria Wealth Solutions, an estimated $2.36M sold.

Based on aggregated 13F filings for Q4 2023.